Clinical Trial Update: LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia [NA]

View source ↗

Summary

Clinical trial registry entry for evaluating the LIAISON NES diagnostic assay for Influenza A/B, RSV, and COVID-19 in symptomatic patients in Australia; not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoviral Infection
• Coronavirus Disease 2019
• Enteroviral Infection
• Parainfluenza Virus Infection
• Pertussis
• Respiratory Syncytial Virus Infection

Drugs mentioned

• LIAISON NES assay (Influenza A/B, RSV, & COVID-19)

Snippet

Sponsor: DiaSorin Molecular LLC | Conditions: Influenza A, Influenza Type B | NA | Status: NOT_YET_RECRUITING